Introduction Monoclonal antibodies (mAbs) remain one of the most widely used therapeutic modalities across oncology, autoimmune diseases, and infectious diseases. In upstream development, accurate and timely measurement of mAb concentration is essential for clone selection, process optimisation, and early screening workflows. Conventional techniques such as enzyme-linked immunosorbent assays (ELISA) and conventional high-performance liquid chromatography (HPLC) [...]

ZEISS and Concept Life Sciences announce partnership Jena, Germany |  ZEISS Research Microscopy Solutions -- ZEISS Microscopy and Concept Life Sciences, a UK-based contract research organization (CRO), announced their collaboration aimed at pioneering new approaches to workflow automation and scalable image analysis in spatial biology. Key focus areas of the collaboration are: Automated high-throughput imaging [...]

Merck KGaA and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry. Memorandum of Understanding signed to deliver end-to-end digital workflows from drug discovery to manufacturing Combines technology from the Siemens Xcelerator Platform and Life Science portfolio of Merck KGaA, Darmstadt, Germany Joint projects include developing AI-driven [...]

-Elevating Performance and Efficiency for Clinical and Public Health Labs- [Wilmington, DE] — LabWare, Inc., the global leader in Laboratory Information Management Systems (LIMS) for more than 30 years, today announces the release of Clinical Health Solution 5.06, the latest version of its purpose-built solution for managing clinical diagnostics and public health laboratory operations. This new release [...]

MoU signed to deliver end-to-end digital workflows from drug discovery to manufacturing through combination of technology from the Siemens Xcelerator platform and Merck's Life Sciences portfolio Joint projects include developing AI-driven tools and digital interfaces that simplify complex scientific processes Merck and Siemens have signed a new Memorandum of Understanding (MoU), extending their strategic partnership [...]

The GCP100 is the first gas chromatograph with built-in cybersecurity on the market It sets a new standard in cybersecurity and real-time analysis of complex gas mixtures, supporting operators in the natural gas, biogas, oil and petrochemical industries with enhanced accuracy and data security The GCP100 covers a wider range of industries and applications thanks [...]

Uppsala, Sweden– Scienta Omicron, a world leader in surface science and photoelectron spectroscopy instrumentation, today announces the launch of DeepCore-X, its newest flagship platform for advanced surface and bulk chemical analysis. DeepCore-X merges high-resolution X-ray Photoelectron Spectroscopy (XPS) and Hard X-ray Photoelectron Spectroscopy (HAXPES, bringing synchrotron-quality insights directly to lab and applied spectroscopy environments. A [...]

A revolutionary advancement in X-ray photoelectron spectroscopy (XPS) depth profiling WALTHAM, Mass. -- Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface Analysis System. This innovative surface analysis instrument represents a leap forward in accurate X-ray photoelectron spectroscopy (XPS) depth-profiling, which is critical for materials scientists around the [...]

A revolutionary advancement in X-ray photoelectron spectroscopy (XPS) depth profiling WALTHAM, Mass. -- Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface Analysis System. This innovative surface analysis instrument represents a leap forward in accurate X-ray photoelectron spectroscopy (XPS) depth-profiling, which is critical for materials scientists around the [...]

BOSTON -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & CDx Summit in Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing (NGS) solution that leverages SOPHiA GENETICS's AI [...]